ImmunityBio, Inc. (IBRX) Deep Dive Video

Name: ImmunityBio, Inc. (IBRX) Deep Dive Video | Flash
Uploaded: 2026-01-20T18:34:08.891
Description: ANKTIVA’s 2025 commercial breakout turns ImmunityBio into a real oncology franchise—if it can outrun 2026–2027 competition and defuse its debt-and-dilution overhang.

Summary

ANKTIVA’s 2025 commercial breakout turns ImmunityBio into a real oncology franchise—if it can outrun 2026–2027 competition and defuse its debt-and-dilution overhang.

View IBRX stock page · Read the IBRX research report

Loading the video player…